
Biotech x Aging Boston: Building, Partnering, Investing
Join us for an evening at the intersection of breakthrough science and capital, as we explore Biotech x Aging Boston: Building, Partnering, Investing.
This is the 2nd event in the Biotech x Aging series from Mindvyne and Celine Biotechnologies. Following the sold-out success of the NYC edition, the Boston gathering will spotlight emerging science in aging and the teams building, funding, and partnering across the full spectrum of aging-focused biotech.
The evening will bring together scientists, startup founders, pharma leaders, investors, and curious minds who want to explore the future of aging innovation and extend active life years. Topics will span neurodegeneration, the impact of infectious diseases on aging, precision diagnostics, platform technologies, and more. The field is advancing quickly, and the funding environment is shifting alongside it.
Our Boston event will be at Merck Digital Sciences Studio and will feature:
– 10-minute science showcase talks with Q&A:
Amy Proal: CEO, PolyBio Research Foundation
Sergiy Velychko: Postsdoc Researcher, Harvard Medical School
– Panel discussion
Aging Innovation from the Ground Up: Insights from Early Innovators
Christin Glorioso: CEO & Co-Founder, NeuroAge
Nina Keshavarzi: CEO & Founder, Celine Biotechnologies
Vidisha Mohad: CEO & Founder, Rasayana Therapeutics
– Panel discussion
Biomarkers and Beyond: What Will Make Aging Biotech Clinically Viable
Mahdi Moqri: Co-Director, Biomarkers of Aging Institute
José Betancourt: Scientific Director, quadraScope
Daniel Carbonero: Investment Associate, PsyMed Ventures
Expect a room full of builders, backers, and collaborators working across the aging biotech landscape. Scientific breakthroughs, new company formation, and fresh funding models are all accelerating, and this event brings those threads together in one place.
The event is free, but space is limited. RSVP now to guarantee entry.
Reach out to Nina or Daniel with any questions!
More Info About Our Sponsors:
Egnyte
Egnyte for Life Sciences is a trusted platform that enhances collaboration and compliance for biotechs throughout the R&D lifecycle. Designed to meet the needs of modern biotechs, our platform provides adaptable, secure features that integrate effortlessly with your existing workflows. With Egnyte, you can implement only the necessary features, reducing costs and complexities while boosting efficiency. Founded in 2007, Egnyte supports growth for emerging biotechs by offering robust data management, regulatory compliance, and seamless integration with your infrastructure, evolving with your needs as you scale.
Reach out to Bryant to learn more.
Event Organizer:
Mindvyne
Mindvyne is your hub for high-caliber networking and collaboration in the life sciences. We curate unique, insightful events that bring together founders, scientists, and industry leaders to foster meaningful discussions and connections.
Beyond events, Mindvyne is building a powerful events platform to streamline event discovery and professional engagement.
Check it out here: www.mindvyne.com